Remember, while these research results are exciting, Dr
you're a cherished member of the Kaua'i Drip community, as we work together towards achieving your optimal state of well-being
Tirzepatide is a 39amino acid dual incretin receptor agonist that activates both GLP1 and GIP receptors, enhancing glucosedependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2]
[1], [2], [3], [4] A 2021 retrospective study conducted at the Institute for Hormonal Balance in Orlando, Florida, that evaluated the use of BPC 157, alone or in combination with thymosin-beta-4 (TB4), indicates in its methodology that no human clinical trials evaluating the use of BPC 157 to help with knee pain have been published (see Table 1)
AMA Formatted References 1
No formal pharmacokinetic study measuring plasma half-life, volume of distribution, or clearance has been published for FOXO4-DRI in any species